The global pen needles market was valued at USD 1,450.0 million in 2019 and is expected to grow at a CAGR of 11.7% over the forecast period. The global pen needles market is projected to grow on account of the growing prevalence of diabetes coupled with the growing need for minimally invasive procedures. According to IDF Diabetes Atlas Ninth edition 2019, approximately 463 million adults (20 to 79 years) are living with diabetes which is anticipated to surpass the mark of 700 million by 2045. Furthermore, in the year 2019; USD 760 billion was spent on healthcare expenditure towards diabetes. All these factors are anticipated to augur market growth over the forecast period.
Request for Sample PDF @ https://www.adroitmarketresearch.com/contacts/request-sample/1550
Adroit Market Research report on global Pen Needles market gives a holistic view of the market from 2015 to 2025, which includes factors such as market drivers, restraints, opportunities, and challenges. The market has been studied for historic years from 2015 to 2019, with the base year of estimation as 2019 and forecast from 2020 to 2025. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market competition with Porter's five forces analysis and company positioning based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global Pen Needles market have been studied in detail.
North America currently holds the majority of the market share owing to the prevalence of diabetes, the presence of a significant number of major players across the region along with growing investments by the established firms. Furthermore, Asia Pacific is anticipated to grow with the highest CAGR owing to the growing patient pool, rising healthcare expenditure, rising disposable income, and growing awareness across the region.
The prominent players operating in global Pen Needles market includes B. Braun Melsungen AG, Ypsomed AG, Owen Mumford Ltd., Novo Nordisk A/S, BD, Terumo Corporation, Allison Medical, Inc., UltiMed, Inc., HTL-Strefa, Arkray, Inc. among other prominent players.
Browse Full Report @ https://www.adroitmarketresearch.com/industry-reports/pen-needles-market
Key segments of the global pen needles market
Product Overview, 2015-2025 (USD Million)
Standard Pen Needles
Safety Pen Needles
Needle Length Overview, 2015-2025 (USD Million)
4mm
5mm
6mm
8mm
10mm
12mm
Therapy Overview, 2015-2025 (USD Million)
Insulin
Glucagon-like-Peptide-1 (GLP-1)
Growth Hormone
Regional Overview, 2015-2025 (USD Million)
North America
U.S.
Canada
Europe
Germany
United Kingdom
France
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Rest of Asia Pacific
Central and South America
Brazil
Mexico
Rest of Central and South America
Middle East & Africa
GCC
Rest of Middle East and Africa
Make an Enquire to Buy This Report @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/1550
About Us:
Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.
Contact Us:
Ryan Johnson
Account Manager - Global
3131 McKinney Ave Ste 600 Dallas, TX 75204, U.S.A
+1 210-667-2421
Email ID: [email protected]
The study involved four major activities in estimating the current market size for pen needles.
The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research.
Thirdly, both top-down and bottom-up approaches were employed to estimate the complete market size.
Finally, the market breakdown and data triangulation method was used to estimate the market size of segments and subsegments.Growth in the Pen Needles Market is mainly driven by factors such as the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries.
The growing preference for biosimilar drugs is another factor providing a wide range of growth opportunities for key players in the market.According to the new market research report “Pen Needles Market by Type (Standard Pen Needles and Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Global Forecast to 2024”, published by MarketsandMarkets™.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=75948613The Pen Needles Market is expected to reach USD 1.8 billion by 2024 from an estimated USD 1.1 billion in 2019, at a CAGR of 10.8% during the forecast period.The insulin therapy segment is expected to grow at the highest CAGR during the forecast periodOn the basis of therapy, the market is categorized into insulin therapy, glucagon-like peptide-1 (GLP-1) therapy, growth hormone therapy, and other therapies.
The insulin therapy segment is expected to grow at the highest CAGR during the forecast period due to the high and growing diabetic population globally.
According to the latest report by Renub Research, titled "Germany Diabetes Market, By Continuous Glucose Monitoring (CGM), Blood Glucose (SMBG) Device, Insulin Pen, Insulin Pump, Reimbursement Company Analysis & Forecast" There are more than 400 Thousand different products summarized as “Medical devices”.
This research study covers the demand of all the four types of diabetes devices - Blood Glucose (SMBG) Device, Insulin Pen, Continuous Glucose Monitoring (CGM) and Insulin Pump.Germany has 7 Million known diabetes population, but according to estimates, about 1.3 Million people are expected to be living with undetected diabetes.
According to German Diabetes Centre (DDZ), type 2 diabetes patients are expected to increase in Germany for 20 years.
Researchers at the German Diabetes Centre (DDZ) estimate that up to twelve million people might suffer from metabolic disorders in 2040.Germany is known for developed countries for advanced healthcare facilities say, for instance, technologies like an insulin pump, insulin pen, continuous glucose monitoring are adopted at a very rapid pace.
Besides, pricing and reimbursement policies were highly regulated in Germany while giving traction to the surging adoption rate of new and advanced technologies.The Factors which are Fueling the Germany Diabetes Market are• Growing Disposable Income• Increasing Geriatric Population• Technological Advancement• Surging Number of Diabetes Population• Increasing Healthcare SpendingFor the key players German diabetes market, it offers a huge opportunity to increase awareness among the people, rising collaboration with international research, advancement in new technologies, and roll-out of many new drugs into the market expanding its market size.Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=germany-diabetes-market-p.phpMarket SummaryMarkets & Users Covered: SMBG, CGM, Insulin Pen and Pump all the four types of Diabetes Devices market and users are covered in the ReportReimbursement Policies: We have studied the Reimbursement Policies of all the four diabetes devices in GermanyContinuous Glucose Monitoring (CGM): CGM Market & User by Components, Glucose Sensor, Transmitter, CGM are covered in this research report.Self Monitoring Blood Glucose Device: By Test Strips, Lancet, Meter - Market & User are given in the report.Insulin Pen: Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market & Users is covered in this research report.By Insulin Pump: This research report covers Insulin Pump Users and Market.By Company: This research report has covered Company overview, recent developments/ initiatives and revenue analysis for B. Braun Melsungen AG, Eli Lilly and Company, Artsana S.p.A, BD, Novo Nordisk A/S, Owen Mumford Ltd, Ypsomed AG, Medtronic, Insulet Corporation, LifeScan Inc., Abbott Laboratories, DexcomInc and Roche.About the Company:Renub Research is a Market Research and Consulting Company.
We provide a wide range of business research solutions that helps companies in making better business decisions.
The Global Safety Lancets Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.
The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.
The report classifies the market into different segments.
These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.
The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global Safety Lancets Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027 @ https://www.decisiondatabases.com/ip/41447-safety-lancet-market-reportThe report also covers the complete competitive landscape of the global Safety Lancets market with company profiles of key players such as: RocheSarstedtBDNiproBayerSmiths MedicalTerumoB.
Autoinjectors Market report published by Value Market Research delivers a comprehensive market analysis covering of market size, share, value, growth and trends for the forecast period of 2020-2026.
The report includes data regarding market attractiveness analysis by segments, company share analysis and recent developments by key players.
Moreover, this market report also covers regional and country market analysis in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the autoinjectors market include Eli Lilly, Biogen Idec, Pfizer, Inc., Mylan N.V., Sanofi, Owen Mumford, Teva Pharmaceutical, Amgen, Ypsomed, Abbvie.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Autoinjectors Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/autoinjectors-market/download-sample Market DynamicsThe widespread increase in self-administration of drug therapies among the global population will be the key driving force behind this market's growth.
The various advantages of an autoinjector can save considerable time and money for the pharmaceutical and biopharmaceutical industries.
The global Diabetes Pen Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the diabetes pen market include AstraZeneca, BD, Eli Lilly and Company, Biocon, Sanofi, delfu-medical.com., Owen Mumford., Wockhardt Limited (India), Smiths Group plc, P Pharmaceuticals Ltd., Nipro Medical Corporation.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Diabetes Pen Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/diabetes-pen-market/download-sampleMarket DynamicsThe rapidly increasing percentage of diabetics and the need for a safe, convenient, and less intrusive approach to inject insulin are the primary trending factors for market growth.
The demand for these diabetes pens is on the rise as people using them are more confident about their dose accuracy.
The pens considered very easy to use by the geriatric population and children will benefit market growth.
